| 摘要 |
Compounds of Formula (I), in which A, B, R1, R1a, R2, R3, R4, R5, R6, and R7 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of immune cell-associated diseases and disorders, such as inflammatory and autoimmune diseases. |
| 申请人 |
ARRAY BIOPHARMA, INC. |
发明人 |
ALLEN, SHELLEY;CELESTE, LAURA L.;DAVIS, T. GREGG;DELISLE, ROBERT KIRK;GRESCHUK, JULIE MARIE;GROSS, STEFAN D.;HICKEN, ERIK JAMES;JACKSON, LEILA J.;LYSSIKATOS, JOSEPH P.;KALLAN, NICHOLAS C.;MARMSATER, FREDRIK P.;MUNSON, MARK C.;PHENEGER, JED;RAST, BRYSON;ROBINSON, JOHN E.;SCHLACHTER, STEPHEN T.;TOPALOV, GEORGE T.;WRIGHT, A. DALE;ZHAO, QIAN |
